Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-09-02
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- GU Research Network, LLC
- Target Recruit Count
- 2
- Registration Number
- NCT02887976
- Locations
- 🇺🇸
GU Research Network/Urology PC, Lincoln, Nebraska, United States
🇺🇸GU Research Network/Wichita Urology Group, Wichita, Kansas, United States
🇺🇸GU Research Network/Urology Cancer Center, Omaha, Nebraska, United States
A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2016-01-25
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- GU Research Network, LLC
- Registration Number
- NCT02662634
- Locations
- 🇺🇸
Cancer Research Network of Nebraska / Oncology Associates, Omaha, Nebraska, United States
© Copyright 2024. All Rights Reserved by MedPath